Loading clinical trials...
Loading clinical trials...
Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
Conditions
Interventions
Biospecimen Collection
Retinoid 9cUAB30
+1 more
Locations
5
United States
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
Northwestern University
Chicago, Illinois, United States
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, United States
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Start Date
March 16, 2018
Primary Completion Date
June 3, 2022
Completion Date
June 3, 2022
Last Updated
June 18, 2024
NCT06401889
NCT06633926
NCT06324240
NCT06763328
NCT05786664
NCT06153836
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions